Lasers in medical science · 2026
Use of fractional and microablative CO2 laser in cases of vulvar lichen sclerosus: a clinical-histological analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
de Assis Pereira Hansen Cavalheiro Dayane, Silva Chuery Ana Carolina, Simões E Silva Enokihara Milvia Maria, Amante Miot Helio, Fillippini Mauricio, de Góis Speck Neila Maria
Аннотация
OBJECTIVE: To evaluate the clinical and histological response of patients with vulvar lichen sclerosus (VLS) following fractional and microablative CO₂ laser treatment.
METHODS: This interventional clinical study included 14 patients diagnosed with VLS. The participants underwent three CO₂ laser sessions with a monthly interval. Clinical assessments and biopsies were performed at baseline and six weeks after the final session. Primary outcomes were improvement in symptoms (Visual Analog Scale - VAS) and clinical signs (Global Aesthetic Improvement Scale - GAIS), associated with histological regression. Secondary outcomes included quality of life (Skindex-29) and specific histological parameters, such as hyperkeratosis, dermal elastic fibers, and type I/III collagen ratio.
RESULTS: All patients reported vulvar pruritus at baseline. After treatment, 50% became asymptomatic (p = 0.016), with a reduction in mean VAS score from 8 to 1 (p = 0.016). Burning sensation, present in 71.4% at baseline, decreased to 28.5% at follow-up (p = 0.031), with VAS scores declining from 6 to 0 (p = 0.008). Clinical improvement assessed by GAIS was observed in up to 64.3% of patients, with high inter-rater agreement (ICC = 0.855). Histological regression occurred in 42.9% of cases (p = 0.031). Quality of life significantly improved across all Skindex-29 domains (p < 0.05). There was a reduction in hyperkeratosis (p = 0.032) and in type I/III collagen ratio (p = 0.022), along with reappearance of dermal elastic fibers (p = 0.024).
CONCLUSION: CO₂ laser therapy reduced symptoms and improved clinical, histological, and quality-of-life outcomes, suggesting therapeutic potential for VLS. Larger controlled studies are warranted.
METHODS: This interventional clinical study included 14 patients diagnosed with VLS. The participants underwent three CO₂ laser sessions with a monthly interval. Clinical assessments and biopsies were performed at baseline and six weeks after the final session. Primary outcomes were improvement in symptoms (Visual Analog Scale - VAS) and clinical signs (Global Aesthetic Improvement Scale - GAIS), associated with histological regression. Secondary outcomes included quality of life (Skindex-29) and specific histological parameters, such as hyperkeratosis, dermal elastic fibers, and type I/III collagen ratio.
RESULTS: All patients reported vulvar pruritus at baseline. After treatment, 50% became asymptomatic (p = 0.016), with a reduction in mean VAS score from 8 to 1 (p = 0.016). Burning sensation, present in 71.4% at baseline, decreased to 28.5% at follow-up (p = 0.031), with VAS scores declining from 6 to 0 (p = 0.008). Clinical improvement assessed by GAIS was observed in up to 64.3% of patients, with high inter-rater agreement (ICC = 0.855). Histological regression occurred in 42.9% of cases (p = 0.031). Quality of life significantly improved across all Skindex-29 domains (p < 0.05). There was a reduction in hyperkeratosis (p = 0.032) and in type I/III collagen ratio (p = 0.022), along with reappearance of dermal elastic fibers (p = 0.024).
CONCLUSION: CO₂ laser therapy reduced symptoms and improved clinical, histological, and quality-of-life outcomes, suggesting therapeutic potential for VLS. Larger controlled studies are warranted.